Deutsche Bank Upgrades Affymetrix (AFFX) to Buy; Risk/Reward Favorable and Transformation Gaining Steam

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. USO
6. AWK
7. GNK
8. ARGX
9. PLUR
10. MU

January 25, 2012 10:02 AM EST
Get Alerts AFFX Hot Sheet
Price: $14.01 --0%

Rating Summary:
    4 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Deutsche Bank upgraded Affymetrix (NASDAQ: AFFX) from Hold to Buy, price target raised from $4.50 to $7.00.

Deutsche analyst says, "We are upgrading AFFX and raising PT on the back of renewed strategic interest in the genomics market (Roche hostile bid for Illumina (Nasdaq: ILMN)). We view the recent CEO change as catalyzing the R&D / commercial organizations, with the recent eBio deal accelerating the company's transition to downstream / applied markets. Our new PT is based on ~2.00x our FY12 revenue estimate of $322.0 million (adjusted for net debt)."

For an analyst ratings summary and ratings history on Affymetrix click here. For more ratings news on Affymetrix click here.

Shares of Affymetrix closed at $4.75 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Deutsche Bank